$CLRB
Cellectar Biosciences, Inc. Stock $clrb

$clrb Overview Financials Valuation SEC Filings Company Website

2014 Q1 Form 10-K Financial Statement

#000114420414016712 Filed on March 19, 2014

Income Statement

Concept	2014 Q1	2013	2012 Q4
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$1.090M	$4.440M	$940.0K
YoY Change	-2.68%	22.31%	9.3%
% of Gross Profit
Research & Development	$1.715M	$6.860M	$1.230M
YoY Change	7.84%	33.92%	6.03%
% of Gross Profit
Depreciation & Amortization	$96.05K	$424.8K	$120.0K
YoY Change	-14.15%	-14.58%	-14.29%
% of Gross Profit
Operating Expenses	$1.715M	$6.860M	$2.160M
YoY Change	7.84%	33.92%	6.93%
Operating Profit	-$2.819M	-$12.40M
YoY Change	3.94%	41.66%
Interest Expense	-$69.24K	-$9.348K	$10.00K
YoY Change	2513.97%	12.15%	-80.0%
% of Operating Profit
Other Income/Expense, Net	-$124.2K	$1.620M	$0.00
YoY Change	-83.25%	-3939.0%
Pretax Income	-$2.940M	-$10.78M	-$2.160M
YoY Change	-14.78%	22.5%	9.64%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$2.943M	-$10.78M	-$2.160M
YoY Change	-14.78%	22.57%	9.64%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share	-$98.00M	-$359.3M	-$108.0M
COMMON SHARES
Basic Shares Outstanding	57.40M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2014 Q1	2013	2012 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$3.810M	$2.420M	$4.680M
YoY Change	-51.53%	-48.29%	-15.06%
Cash & Equivalents	$3.808M	$2.420M	$4.678M
Short-Term Investments
Other Short-Term Assets	$270.0K	$350.0K	$460.0K
YoY Change	8.0%	-23.91%	48.39%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$4.075M	$2.770M	$5.130M
YoY Change	-49.75%	-46.0%	-11.79%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.280M	$2.360M	$2.645M
YoY Change	-12.98%	-10.94%	-13.12%
Goodwill			$1.675M
YoY Change			0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$10.00K	$10.00K	$27.22K
YoY Change	-99.48%	-99.51%	0.0%
Total Long-Term Assets	$3.965M	$4.050M	$6.348M
YoY Change	-36.05%	-36.22%	33.71%
TOTAL ASSETS
Total Short-Term Assets	$4.075M	$2.770M	$5.130M
Total Long-Term Assets	$3.965M	$4.050M	$6.348M
Total Assets	$8.040M	$6.820M	$11.48M
YoY Change	-43.82%	-40.59%	8.66%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$940.0K	$1.160M	$720.0K
YoY Change	9.3%	61.11%	50.0%
Accrued Expenses	$50.00K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$0.00	$0.00	$0.00
YoY Change
Total Short-Term Liabilities	$4.410M	$4.520M	$732.7K
YoY Change	-33.08%	519.18%	45.5%
LONG-TERM LIABILITIES
Long-Term Debt	$4.220M	$450.0K	$450.0K
YoY Change	837.78%	0.0%	0.0%
Other Long-Term Liabilities	$140.0K	$140.0K	$140.0K
YoY Change	0.0%	0.0%	16.67%
Total Long-Term Liabilities	$4.360M	$590.0K	$587.1K
YoY Change	638.92%	0.0%	1.49%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.410M	$4.520M	$732.7K
Total Long-Term Liabilities	$4.360M	$590.0K	$587.1K
Total Liabilities	$8.767M	$5.120M	$1.320M
YoY Change	22.11%	287.88%	21.97%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock			$464.00
YoY Change			25.75%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$730.0K	$1.700M	$10.16M
YoY Change
Total Liabilities & Shareholders Equity	$8.040M	$6.820M	$11.48M
YoY Change	-43.82%	-40.59%	8.66%

Cashflow Statement

Concept	2014 Q1	2013	2012 Q4
OPERATING ACTIVITIES
Net Income	-$2.943M	-$10.78M	-$2.160M
YoY Change	-14.78%	22.57%	9.64%
Depreciation, Depletion And Amortization	$96.05K	$424.8K	$120.0K
YoY Change	-14.15%	-14.58%	-14.29%
Cash From Operating Activities	-$2.590M	-$9.150M	-$1.700M
YoY Change	37.04%	38.85%	10.39%
INVESTING ACTIVITIES
Capital Expenditures	$15.19K	$147.8K	-$60.00K
YoY Change	-83.66%	51.31%	500.0%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$2.000M	-$2.000M
YoY Change	-100.0%	-200.0%
Cash From Investing Activities	-$20.00K	$1.850M	-$2.060M
YoY Change	-166.67%	-188.1%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$0.00	-$4.975M
YoY Change	-100.0%	-27.25%
Debt Paid & Issued, Net	$0.00	$0.00
YoY Change
Cash From Financing Activities	4.000M	5.040M	2.830M
YoY Change	-20.79%	-35.8%	-48.17%
NET CHANGE
Cash From Operating Activities	-2.590M	-9.150M	-1.700M
Cash From Investing Activities	-20.00K	1.850M	-2.060M
Cash From Financing Activities	4.000M	5.040M	2.830M
Net Change In Cash	1.390M	-2.260M	-930.0K
YoY Change	-56.43%	169.05%	-123.72%
FREE CASH FLOW
Cash From Operating Activities	-$2.590M	-$9.150M	-$1.700M
Capital Expenditures	$15.19K	$147.8K	-$60.00K
Free Cash Flow	-$2.605M	-$9.298M	-$1.640M
YoY Change	31.38%	39.03%	7.19%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2013Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4677545	USD
CY2012Q4	us-gaap	Restricted Cash And Investments Current RestrictedCashAndInvestmentsCurrent	55000	USD
CY2012Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	327393	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2418384	USD
CY2013Q4	us-gaap	Restricted Cash And Investments Current RestrictedCashAndInvestmentsCurrent	55000	USD
CY2013Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	294687	USD
CY2012Q4	clrb	Deferred Financing DeferredFinancing	70539	USD
CY2013Q4	clrb	Deferred Financing DeferredFinancing	0	USD
CY2012Q4	us-gaap	Assets Current AssetsCurrent	5130477	USD
CY2013Q4	us-gaap	Assets Current AssetsCurrent	2768071	USD
CY2012Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	2000000	USD
CY2013Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	0	USD
CY2012Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2645003	USD
CY2013Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2360534	USD
CY2012Q4	us-gaap	Goodwill Goodwill	1675462	USD
CY2013Q4	us-gaap	Goodwill Goodwill	1675462	USD
CY2012Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	27222	USD
CY2013Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	11872	USD
CY2012Q4	us-gaap	Assets Assets	11478164	USD
CY2013Q4	us-gaap	Assets Assets	6815939	USD
CY2012Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	716990	USD
CY2013Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1162098	USD
CY2012Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	13304	USD
CY2013Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	3359363	USD
CY2012Q4	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	2397	USD
CY2013Q4	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	1694	USD
CY2012Q4	us-gaap	Liabilities Current LiabilitiesCurrent	732691	USD
CY2013Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4523155	USD
CY2012Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	450000	USD
CY2013Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	450000	USD
CY2012Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	135404	USD
CY2013Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	143234	USD
CY2012Q4	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	1694	USD
CY2013Q4	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	0	USD
CY2012Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	587098	USD
CY2013Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	593234	USD
CY2012Q4	us-gaap	Liabilities Liabilities	1319789	USD
CY2013Q4	us-gaap	Liabilities Liabilities	5116389	USD
CY2012Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2012Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2013Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2012Q4	us-gaap	Common Stock Value CommonStockValue	464	USD
CY2013Q4	us-gaap	Common Stock Value CommonStockValue	574	USD
CY2012Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	50435311	USD
CY2013Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	52758544	USD
CY2012Q4	us-gaap	Development Stage Enterprise Deficit Accumulated During Development Stage DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage	40277400	USD
CY2013	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-48056	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	263167	USD
CY2012	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	238949	USD
CY2013Q4	us-gaap	Development Stage Enterprise Deficit Accumulated During Development Stage DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage	51059568	USD
CY2012Q4	us-gaap	Stockholders Equity StockholdersEquity	10158375	USD
CY2013Q4	us-gaap	Stockholders Equity StockholdersEquity	1699550	USD
CY2012Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	11478164	USD
CY2013Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6815939	USD
CY2013Q4	clrb	Number Of Shares Issuable Upon Exercise Of Outstanding Warrants NumberOfSharesIssuableUponExerciseOfOutstandingWarrants	36782459	shares
CY2013	clrb	Fair Value Of Warrants Classified As Derivative Liability FairValueOfWarrantsClassifiedAsDerivativeLiability	5720000	USD
CY2013	clrb	Warrants Expiration Date WarrantsExpirationDate	2014-02-20
CY2013	clrb	Change In Unrealized Gain Loss On Fair Value ChangeInUnrealizedGainLossOnFairValue	2365000	USD
CY2012	us-gaap	Share Based Compensation ShareBasedCompensation	1503297	USD
CY2013	us-gaap	Share Based Compensation ShareBasedCompensation	2323233	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	6681403	USD
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	1.09	pure
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2012	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.75
CY2013	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.46
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.62
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.28
CY2002Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	0	shares
CY2011	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	6240083	shares
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	1956650	shares
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	6885573	shares
CY2011	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	459876	shares
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	343434	shares
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	442555	shares
CY2011Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	4827638	shares
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	6439188	shares
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	12693166	shares
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	4906718	shares
CY2013Q4	clrb	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Options Unvested Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsUnvestedOutstandingNumber	7786448	shares
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	4906718	shares
CY2011	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.35
CY2012	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.75
CY2013	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.46
CY2011	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	2.46
CY2012	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	1.38
CY2013	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0.78
CY2011Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.82
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.52
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.91
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	1.55
CY2013Q4	clrb	Share Based Compensation Arrangement By Share Based Payment Award Options Non Vested Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonVestedExercisableWeightedAverageExercisePrice	0.50
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	1.55
CY2013	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P4Y2M1D
CY2013	clrb	Share Based Compensation Arrangement By Share Based Payment Award Options Unvested Outstanding Weighted Average Remaining Contractual Term ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedOutstandingWeightedAverageRemainingContractualTerm	P9Y7M20D
CY2013	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P4Y2M1D
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	0	USD
CY2013Q4	clrb	Share Based Compensation Arrangement By Share Based Payment Award Options Unvested Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedOutstandingAggregateIntrinsicValue	134400	USD
CY2013Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	0	USD
CY2013	clrb	Share Based Compensation Arrangement By Share Based Payment Award Options Unvested Compensation Cost ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedCompensationCost	2045527	USD
CY2013	clrb	Employee Service Share Based Compensation Nonvested Total Compensation In Current Year EmployeeServiceShareBasedCompensationNonvestedTotalCompensationInCurrentYear	607116	USD
CY2013	clrb	Employee Service Share Based Compensation Nonvested Total Compensation In Year Two EmployeeServiceShareBasedCompensationNonvestedTotalCompensationInYearTwo	450336	USD
CY2013	clrb	Employee Service Share Based Compensation Nonvested Total Compensation In Year Three EmployeeServiceShareBasedCompensationNonvestedTotalCompensationInYearThree	323536	USD
CY2013	clrb	Employee Service Share Based Compensation Nonvested Total Compensation In Year Four EmployeeServiceShareBasedCompensationNonvestedTotalCompensationInYearFour	172363	USD
CY2012Q4	clrb	Weighted Average Grant Date Fair Value Of Vested Options Outstanding WeightedAverageGrantDateFairValueOfVestedOptionsOutstanding	1.01
CY2013Q4	clrb	Weighted Average Grant Date Fair Value Of Vested Options Outstanding WeightedAverageGrantDateFairValueOfVestedOptionsOutstanding	0.88
CY2012Q4	clrb	Weighted Average Grant Date Fair Value Of Unvested Options Outstanding WeightedAverageGrantDateFairValueOfUnvestedOptionsOutstanding	0.73
CY2013Q4	clrb	Weighted Average Grant Date Fair Value Of Unvested Options Outstanding WeightedAverageGrantDateFairValueOfUnvestedOptionsOutstanding	0.33
CY2013Q4	clrb	Share Based Compensation Arrangement By Sharebased Payment Award Options Unvested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsUnvestedAndExpectedToVestOutstandingNumber	5860873	shares
CY2012Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2013Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2012Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	7000	shares
CY2013Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	7000	shares
CY2012Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2013Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2012Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2013Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2012Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2013Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2012Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2013Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2012Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	46397997	shares
CY2013Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	57397997	shares
CY2012Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	46397997	shares
CY2013Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	57397997	shares
CY2012	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5122686	USD
CY2013	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6860163	USD
CY2012	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3632099	USD
CY2012	us-gaap	Business Combination Separately Recognized Transactions Additional Disclosures Acquisition Cost Expensed BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCostExpensed	0	USD
CY2013	us-gaap	Business Combination Separately Recognized Transactions Additional Disclosures Acquisition Cost Expensed BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCostExpensed	0	USD
	us-gaap	Business Combination Separately Recognized Transactions Additional Disclosures Acquisition Cost Expensed BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCostExpensed	799133	USD
CY2013	us-gaap	Costs And Expenses CostsAndExpenses	12401804	USD
	us-gaap	Costs And Expenses CostsAndExpenses	52423372	USD
CY2012	us-gaap	Operating Income Loss OperatingIncomeLoss	-8754785	USD
CY2013	us-gaap	Operating Income Loss OperatingIncomeLoss	-12401804	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-52423372	USD
CY2012	us-gaap	Revenue From Grants RevenueFromGrants	0	USD
CY2013	us-gaap	Revenue From Grants RevenueFromGrants	0	USD
	us-gaap	Revenue From Grants RevenueFromGrants	244479	USD
CY2012	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	-33854	USD
CY2013	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	2373941	USD
	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	2327929	USD
CY2013	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-744957	USD
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-744957	USD
CY2012	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-8335	USD
CY2013	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-9348	USD
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-464808	USD
CY2012	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	0	USD
CY2013	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	0	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1161	USD
CY2012	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-42189	USD
CY2013	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1619636	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1363804	USD
CY2012	us-gaap	Net Income Loss NetIncomeLoss	-8796974	USD
CY2013	us-gaap	Net Income Loss NetIncomeLoss	-10782168	USD
	us-gaap	Net Income Loss NetIncomeLoss	-51059568	USD
CY2012	clrb	Deemed Dividend On Warrants DeemedDividendOnWarrants	-543359	USD
CY2013	clrb	Deemed Dividend On Warrants DeemedDividendOnWarrants	0	USD
	clrb	Deemed Dividend On Warrants DeemedDividendOnWarrants	-543359	USD
CY2012	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-9340333	USD
CY2013	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-10782168	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-51602927	USD
CY2012	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.23
CY2013	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.19
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-2.90
CY2012	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	41121137	shares
CY2013	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	55891148	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	17791745	shares
CY2012	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	497253	USD
CY2013	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	424758	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	3338049	USD
CY2012	us-gaap	Debt Instrument Convertible Beneficial Conversion Feature DebtInstrumentConvertibleBeneficialConversionFeature	0	USD
CY2013	us-gaap	Debt Instrument Convertible Beneficial Conversion Feature DebtInstrumentConvertibleBeneficialConversionFeature	0	USD
	us-gaap	Debt Instrument Convertible Beneficial Conversion Feature DebtInstrumentConvertibleBeneficialConversionFeature	-471765	USD
CY2012	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	0	USD
CY2013	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	0	USD
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	89520	USD
CY2012	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	0	USD
CY2013	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	0	USD
	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	19671	USD
CY2012	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	USD
CY2013	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-7523	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-44000	USD
CY2012	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	72426	USD
CY2013	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	445108	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	781969	USD
CY2012	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	0	USD
CY2013	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	0	USD
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	463722	USD
CY2012	us-gaap	Increase Decrease In Deferred Liabilities IncreaseDecreaseInDeferredLiabilities	11023	USD
CY2013	us-gaap	Increase Decrease In Deferred Liabilities IncreaseDecreaseInDeferredLiabilities	7830	USD
	us-gaap	Increase Decrease In Deferred Liabilities IncreaseDecreaseInDeferredLiabilities	143234	USD
CY2012	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-6585024	USD
CY2013	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-9154644	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-40872374	USD
CY2012	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	0	USD
CY2013	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	0	USD
	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	905649	USD
CY2012	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	97691	USD
CY2013	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	147812	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	5732095	USD
CY2012	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	USD
CY2013	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	USD
	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	55000	USD
CY2012	us-gaap	Proceeds From Sale Maturity And Collection Of Shortterm Investments ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments	0	USD
CY2013	us-gaap	Proceeds From Sale Maturity And Collection Of Shortterm Investments ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments	0	USD
	us-gaap	Proceeds From Sale Maturity And Collection Of Shortterm Investments ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments	5500730	USD
CY2012	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	2000000	USD
CY2013	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	-2000000	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	7000	USD
CY2012	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	0	USD
CY2013	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	0	USD
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	5500730	USD
CY2012	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	0	USD
CY2013	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	0	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	19671	USD
CY2012	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-2097691	USD
CY2013	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	1852188	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-4894117	USD
CY2012	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0	USD
CY2013	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0	USD
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	2720985	USD
CY2012	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	USD
CY2013	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	USD
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	1677945	USD
CY2012	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	0	USD
CY2013	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	0	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	1227944	USD
CY2012	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	2235	USD
CY2013	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	2397	USD
	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	9280	USD
CY2012	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	6838774	USD
CY2013	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	4975153	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	43688181	USD
CY2012	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	1088300	USD
CY2013	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	USD
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	1338300	USD
CY2012	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
CY2013	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	31667	USD
CY2012	us-gaap	Payments Of Merger Related Costs Financing Activities PaymentsOfMergerRelatedCostsFinancingActivities	0	USD
CY2013	us-gaap	Payments Of Merger Related Costs Financing Activities PaymentsOfMergerRelatedCostsFinancingActivities	0	USD
	us-gaap	Payments Of Merger Related Costs Financing Activities PaymentsOfMergerRelatedCostsFinancingActivities	145	USD
CY2012	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-70539	USD
CY2013	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	70539	USD
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	28500	USD
CY2012	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	7854300	USD
CY2013	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	5043295	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	48184875	USD
CY2012	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-828415	USD
CY2013	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-2259161	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	2418384	USD
CY2011Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5505960	USD
CY2002Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	0	USD
CY2012	clrb	Fair Value Of Warrants Classified As Derivative Liability FairValueOfWarrantsClassifiedAsDerivativeLiability	0	USD
	clrb	Fair Value Of Warrants Classified As Derivative Liability FairValueOfWarrantsClassifiedAsDerivativeLiability	5720000	USD
CY2012	us-gaap	Interest Paid InterestPaid	0	USD
CY2013	us-gaap	Interest Paid InterestPaid	0	USD
	us-gaap	Interest Paid InterestPaid	208689	USD
CY2013	clrb	Reclassification Of Derivative Liabilities To Additional Paid In Capital ReclassificationOfDerivativeLiabilitiesToAdditionalPaidInCapital	0	USD
	clrb	Reclassification Of Derivative Liabilities To Additional Paid In Capital ReclassificationOfDerivativeLiabilitiesToAdditionalPaidInCapital	92194	USD
CY2012	clrb	Issuance Of Common Stock In Exchange For Convertible Notes IssuanceOfCommonStockInExchangeForConvertibleNotes	0	USD
CY2013	clrb	Issuance Of Common Stock In Exchange For Convertible Notes IssuanceOfCommonStockInExchangeForConvertibleNotes	0	USD
	clrb	Issuance Of Common Stock In Exchange For Convertible Notes IssuanceOfCommonStockInExchangeForConvertibleNotes	3184707	USD
CY2012	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	0	USD
CY2013	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	0	USD
	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	78407	USD
CY2012	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	0	USD
CY2012	clrb	Reclassification Of Derivative Liabilities To Additional Paid In Capital ReclassificationOfDerivativeLiabilitiesToAdditionalPaidInCapital	43855	USD
CY2013	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	0	USD
	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	439615	USD
CY2012	clrb	Supplemental Goodwill SupplementalGoodwill	0	USD
CY2013	clrb	Supplemental Goodwill SupplementalGoodwill	0	USD
	clrb	Supplemental Goodwill SupplementalGoodwill	1675462	USD
CY2002Q4	us-gaap	Stockholders Equity StockholdersEquity	0	USD
CY2003Q4	us-gaap	Stockholders Equity StockholdersEquity	388936	USD
CY2004Q4	us-gaap	Stockholders Equity StockholdersEquity	46175	USD
CY2005Q4	us-gaap	Stockholders Equity StockholdersEquity	400206	USD
CY2006Q4	us-gaap	Stockholders Equity StockholdersEquity	6546165	USD
CY2007Q4	us-gaap	Stockholders Equity StockholdersEquity	2526232	USD
CY2008Q4	us-gaap	Stockholders Equity StockholdersEquity	9844567	USD
CY2009Q4	us-gaap	Stockholders Equity StockholdersEquity	4126893	USD
CY2010Q4	us-gaap	Stockholders Equity StockholdersEquity	133762	USD
CY2011Q4	us-gaap	Stockholders Equity StockholdersEquity	9481123	USD
CY2002Q4	us-gaap	Stockholders Equity StockholdersEquity	599377	USD
CY2003	us-gaap	Net Income Loss NetIncomeLoss	-295790	USD
CY2004	us-gaap	Net Income Loss NetIncomeLoss	-342761	USD
CY2005	us-gaap	Net Income Loss NetIncomeLoss	-481837	USD
CY2006	us-gaap	Net Income Loss NetIncomeLoss	-963440	USD
CY2007	us-gaap	Net Income Loss NetIncomeLoss	-5090325	USD
CY2008	us-gaap	Net Income Loss NetIncomeLoss	-6090715	USD
CY2009	us-gaap	Net Income Loss NetIncomeLoss	-6219873	USD
CY2010	us-gaap	Net Income Loss NetIncomeLoss	-4560263	USD
CY2011	us-gaap	Net Income Loss NetIncomeLoss	-7435422	USD
CY2002Q4	us-gaap	Net Income Loss NetIncomeLoss	0	USD
CY2006	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	31667	USD
CY2006	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	43994	USD
CY2007	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	570392	USD
CY2008	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	477488	USD
CY2009	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	502199	USD
CY2010	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	353340	USD
CY2011	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	907460	USD
CY2012	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1503297	USD
CY2013	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2323233	USD
CY2007	clrb	Stock Issued During Period Value Stock Warrants Exercised StockIssuedDuringPeriodValueStockWarrantsExercised	250000	USD
CY2010	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	213792	USD
CY2011	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	257973	USD
CY2011	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	3184707	USD
CY2011	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	2219903	USD
CY2011	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	-145	USD
CY2011	clrb	Issuance Of Common Stock And Warrants Value IssuanceOfCommonStockAndWarrantsValue	10164546	USD
CY2012	clrb	Issuance Of Common Stock And Warrants Value IssuanceOfCommonStockAndWarrantsValue	6838774	USD
CY2013	clrb	Issuance Of Common Stock And Warrants Value IssuanceOfCommonStockAndWarrantsValue	4975153	USD
CY2011	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	48339	USD
CY2012	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	43855	USD
CY2012	clrb	Issuance Of Common Stock Upon Exercise Of Warrants In Value IssuanceOfCommonStockUponExerciseOfWarrantsInValue	1088300	USD
CY2013	dei	Document Type DocumentType	10-K
CY2013	dei	Amendment Flag AmendmentFlag	false
CY2013	dei	Document Period End Date DocumentPeriodEndDate	2013-12-31
CY2013	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2013
CY2013	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2013	dei	Trading Symbol TradingSymbol	CLRB
CY2014Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	57397997	shares
CY2013	dei	Entity Registrant Name EntityRegistrantName	Cellectar Biosciences, Inc.
CY2013	dei	Entity Central Index Key EntityCentralIndexKey	0001279704
CY2013	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2013	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2013	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2013	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2013	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
CY2013Q2	dei	Entity Public Float EntityPublicFloat	20803940	USD
CY2012	us-gaap	Restructuring Costs RestructuringCosts	0	USD
CY2013	us-gaap	Restructuring Costs RestructuringCosts	1096874	USD
	us-gaap	Restructuring Costs RestructuringCosts	1096874	USD
CY2012	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	0	USD
CY2013	clrb	Adjustments To Additional Paid In Capital Fair Value Of Warrants Issued Common Stock AdjustmentsToAdditionalPaidInCapitalFairValueOfWarrantsIssuedCommonStock	-4975043	USD
CY2013Q4	clrb	Warrants Issued To Purchase Common Stock WarrantsIssuedToPurchaseCommonStock	5500000	shares
CY2013	us-gaap	Use Of Estimates UseOfEstimates	<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <b><i><font style="FONT-SIZE: 10pt">Use of Estimates</font></i></b> <font style="FONT-SIZE: 10pt"> The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and judgments that may affect the reported amounts of assets, liabilities, revenue and expenses and disclosure of contingent assets and liabilities. On an on-going basis, management evaluates its estimates including those related to unbilled vendor amounts and share-based compensation. Management bases its estimates on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities. Actual results may differ from those estimates under different assumptions or conditions. Changes in estimates are reflected in reported results in the period in which they become known.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2012Q4	clrb	Long Term Restricted Asset LongTermRestrictedAsset	2000000	USD
CY2013	us-gaap	Property Plant And Equipment Useful Life PropertyPlantAndEquipmentUsefulLife	P5Y
CY2013	clrb	Lease Term LeaseTerm	P3Y
CY2012Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	27310	shares
CY2013Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	16527310	shares
CY2013	us-gaap	Restructuring Charges RestructuringCharges	1097000	USD
CY2013	clrb	Severance And Retention Expense SeveranceAndRetentionExpense	386000	USD
CY2013	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; COLOR: black; FONT-SIZE: 10pt"> <font style="BACKGROUND: transparent"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"><b><i>Concentration of Credit Risk</i></b></font></font> Financial instruments that subject the Company to credit risk consist of cash and equivalents on deposit with financial institutions. The Company’s excess cash as of December 31, 2013 and 2012 is on deposit in a non-interest-bearing transaction account with a well-established financial institution.<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; COLOR: black; FONT-SIZE: 10pt"> At times, s<font style="BACKGROUND: transparent">uch deposits may be in excess of the Federal Deposit Insurance Corporation insurance limits. As of December 31, 2013, uninsured cash balances totaled approximately $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">2,165,000</font>.</font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2013Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	2000000	USD
CY2012Q4	us-gaap	Certificates Of Deposit At Carrying Value CertificatesOfDepositAtCarryingValue	55000	USD
CY2013Q4	us-gaap	Certificates Of Deposit At Carrying Value CertificatesOfDepositAtCarryingValue	55000	USD
CY2013	us-gaap	Other Restructuring Costs OtherRestructuringCosts	5000	USD
CY2013	us-gaap	Payments For Restructuring PaymentsForRestructuring	200000	USD
CY2012Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	5493055	USD
CY2013Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	5625482	USD
CY2012Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2848052	USD
CY2013Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3264948	USD
CY2012	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2013	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2012	clrb	Number Of Shares Reserved For Future Issuance NumberOfSharesReservedForFutureIssuance	27951647	shares
CY2013	clrb	Number Of Shares Reserved For Future Issuance NumberOfSharesReservedForFutureIssuance	49475625	shares
CY2013Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	94000	USD
CY2013Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	0	USD
CY2013Q4	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	0	USD
CY2013Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	94000	USD
CY2007	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	8050	USD
CY2012	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	227000	USD
CY2013	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	229000	USD
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	1597000	USD
CY2013	clrb	Lease Rent Escalation Percentage LeaseRentEscalationPercentage	0.03	pure
CY2012	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	0	USD
CY2013	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	0	USD
CY2012	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0	USD
CY2013	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0	USD
CY2012	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-3225486	USD
CY2013	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-4705250	USD
CY2012	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	2291913	USD
CY2013	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	134225	USD
CY2012	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-933573	USD
CY2013	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-4571025	USD
CY2012	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2013	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2012	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	933573	USD
CY2013	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	4571025	USD
CY2003Q3	clrb	Payment Of License Fee PaymentOfLicenseFee	10000	USD
CY2003Q3	clrb	Payment Of Sublicense Fee Description PaymentOfSublicenseFeeDescription	if the sublicense fee payable to the Company is between 4% and 5% of net sales, then the royalties payable to U. Mich. Shall be equal to 50% of the sublicense fee.
CY2003Q3	clrb	Percentage Of Revenue Received In Kind PercentageOfRevenueReceivedInKind	0.1	pure
CY2013	clrb	Payment Of Lump Sum Amount Related To Employment Agreement PaymentOfLumpSumAmountRelatedToEmploymentAgreement	112379	USD
CY2013	clrb	Payment Of Retention Bonus PaymentOfRetentionBonus	67427	USD
CY2012Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	271049	USD
CY2013Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	257314	USD
CY2012Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	271049	USD
CY2013Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	257314	USD
CY2012Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	39347745	USD
CY2013Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	43918772	USD
CY2012Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	39347745	USD
CY2013Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	43918772	USD
CY2012Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	USD
CY2013Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	USD
CY2013Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	0	USD
CY2013Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	119957	USD
CY2013Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	243591	USD
CY2013Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	86452	USD
CY2013Q4	us-gaap	Long Term Debt LongTermDebt	450000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	842174	USD
CY2013Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	1599005	USD
CY2012Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	440556	USD
CY2013Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	380339	USD
CY2012Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	39618794	USD
CY2013Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	44176086	USD
CY2012Q4	us-gaap	Deferred Tax Assets Charitable Contribution Carryforwards DeferredTaxAssetsCharitableContributionCarryforwards	43350	USD
CY2013Q4	us-gaap	Deferred Tax Assets Charitable Contribution Carryforwards DeferredTaxAssetsCharitableContributionCarryforwards	34850	USD
CY2012Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	25199	USD
CY2013Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	26112	USD
CY2012Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	22343084	USD
CY2013Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	25731718	USD
CY2012Q4	clrb	Deferred Tax Assets Tax Credit Carry Forwards Domestic Research And Development DeferredTaxAssetsTaxCreditCarryForwardsDomesticResearchAndDevelopment	1969426	USD
CY2013Q4	clrb	Deferred Tax Assets Tax Credit Carry Forwards Domestic Research And Development DeferredTaxAssetsTaxCreditCarryForwardsDomesticResearchAndDevelopment	2480417	USD
CY2012Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	2252566	USD
CY2013Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	2070642	USD
CY2012Q4	clrb	Deferred Tax Assets Tax Credit Carry Forwards State And Local Research And Development DeferredTaxAssetsTaxCreditCarryForwardsStateAndLocalResearchAndDevelopment	633571	USD
CY2013Q4	clrb	Deferred Tax Assets Tax Credit Carry Forwards State And Local Research And Development DeferredTaxAssetsTaxCreditCarryForwardsStateAndLocalResearchAndDevelopment	724200	USD
CY2012Q4	clrb	Deferred Tax Assets Deferred Expense Capitalized Research And Development Costs DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts	11068868	USD
CY2013Q4	clrb	Deferred Tax Assets Deferred Expense Capitalized Research And Development Costs DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts	11128803	USD
CY2012	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.3400	pure
CY2013	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.3400	pure
CY2012	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.1720	pure
CY2013	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.0082	pure
CY2012	clrb	Effective Income Tax Rate Reconciliation Permanent Adjustment EffectiveIncomeTaxRateReconciliationPermanentAdjustment	-0.0017	pure
CY2013	clrb	Effective Income Tax Rate Reconciliation Permanent Adjustment EffectiveIncomeTaxRateReconciliationPermanentAdjustment	0.0510	pure
CY2010Q3	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	450000	USD
CY2012	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.1061	pure
CY2013	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.4240	pure
CY2012	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.0602	pure
CY2013	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.0412	pure
CY2012	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2013	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2010	clrb	Percentage Of Late Payment Charges PercentageOfLatePaymentCharges	0.12	pure
CY2013	clrb	Unpaid Principal And Interest Description UnpaidPrincipalAndInterestDescription	Monthly payments of $20,665 for principal and interest commence on May 1, 2015 and continue for 23 equal installments with the final installment of any remaining unpaid principal and interest due on April 1, 2017.
CY2010	clrb	Interest And Principal Payments Period InterestAndPrincipalPaymentsPeriod	2015-04-30
CY2012	us-gaap	Interest Expense Long Term Debt InterestExpenseLongTermDebt	9000	USD
CY2013	us-gaap	Interest Expense Long Term Debt InterestExpenseLongTermDebt	9000	USD
CY2013	clrb	Lease Rent Expansion Space LeaseRentExpansionSpace	1140	USD
CY2013	clrb	Maximum Renovation Expense MaximumRenovationExpense	55000	USD
CY2013	clrb	Reimbursement Of Rental Costs ReimbursementOfRentalCosts	4000	USD
CY2013	clrb	Warrants Unexercised WarrantsUnexercised	5500000	shares
CY2013	clrb	Resale Of Shares Of Common Stock ResaleOfSharesOfCommonStock	4000000	shares
CY2012	clrb	Share Based Compensation Arrangement By Share Based Payment Award Options Cancelled In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledInPeriod	1666	shares
CY2013	clrb	Share Based Compensation Arrangement By Share Based Payment Award Options Cancelled In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledInPeriod	189040	shares
CY2011	clrb	Share Based Compensation Arrangement By Share Based Payment Award Options Cancelled Two In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledTwoInPeriod	1001728	shares
CY2012	clrb	Share Based Compensation Arrangements By Share Based Payment Award Options Cancelled In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsCancelledInPeriodWeightedAverageExercisePrice	0.45
CY2013	clrb	Share Based Compensation Arrangements By Share Based Payment Award Options Cancelled In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsCancelledInPeriodWeightedAverageExercisePrice	5.89
CY2011	clrb	Share Based Compensation Arrangements By Share Based Payment Award Options Cancelled Two In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsCancelledTwoInPeriodWeightedAverageExercisePrice	3.80
CY2011	clrb	Share Based Compensation Arrangement By Share Based Payment Award Option Acquired In Connection With Business Combination In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionAcquiredInConnectionWithBusinessCombinationInPeriod	49159	shares
CY2011	clrb	Share Based Compensation Arrangements By Share Based Payment Award Options Acquired In Connection With Busniess Combination In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAcquiredInConnectionWithBusniessCombinationInPeriodWeightedAverageExercisePrice	100.52
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	3340131	shares
CY2013	clrb	Warrants To Purchase Common Stock WarrantsToPurchaseCommonStock	36585895	shares
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Incremental Compensation Cost ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost	136022	USD
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Incremental Compensation Cost ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost	171835	USD
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Accelerated Compensation Cost ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost	569496	USD
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Accelerated Compensation Cost ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost	101972	USD
CY2013	clrb	Shares Issued Upon Warrants Exercise SharesIssuedUponWarrantsExercise	19	shares
CY2013	clrb	Estimated Stock Based Compensation Expense Up On Vesting Of Options EstimatedStockBasedCompensationExpenseUpOnVestingOfOptions	492176	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.82
CY2012	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	1549300	USD
CY2013	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	2109200	USD
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	6464900	USD
CY2013Q4	clrb	Expansion Space For Lease ExpansionSpaceForLease	3400	sqft
CY2013Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	2165000	USD

Files In Submission

Name	View Source	Status
0001144204-14-016712-index-headers.html	Edgar Link	pending
0001144204-14-016712-index.html	Edgar Link	pending
0001144204-14-016712.txt	Edgar Link	pending
0001144204-14-016712-xbrl.zip	Edgar Link	pending
clrb-20131231.xml	Edgar Link	completed
clrb-20131231.xsd	Edgar Link	pending
clrb-20131231_cal.xml	Edgar Link	unprocessable
clrb-20131231_def.xml	Edgar Link	unprocessable
clrb-20131231_lab.xml	Edgar Link	unprocessable
clrb-20131231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
v369226_10k.htm	Edgar Link	pending
v369226_ex21-1.htm	Edgar Link	pending
v369226_ex31-1.htm	Edgar Link	pending
v369226_ex31-2.htm	Edgar Link	pending
v369226_ex32-1.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CLRB
Cellectar Biosciences, Inc. Stock $clrb

2014 Q1 Form 10-K Financial Statement

#000114420414016712 Filed on March 19, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CLRB Cellectar Biosciences, Inc. Stock $clrb

2014 Q1 Form 10-K Financial Statement

#000114420414016712 Filed on March 19, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CLRB
Cellectar Biosciences, Inc. Stock $clrb